Code | 5053E | ||||||||||
MA number | 59/0260/23-S | ||||||||||
Product Form: | cps end 14x120 mg (blis.PVC/PVDC/Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 30 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 30.12.2023 |
Validity: | 30.12.2028 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Nideolo_12_2023.pdf |
SPC: | SPC_Nideolo_12_2023.pdf |
Safety feature | Yes |
Data update: | 10.01.2024 |